<DOC>
	<DOCNO>NCT02059629</DOCNO>
	<brief_summary>The Eluna Family / Sentus BP Master Study design confirm safety new Eluna pacemaker family Sentus BP ( bipolar ) leave ventricular lead . Furthermore new wandless RF telemetry function `` SafeSync '' handle Sentus lead implantation assess .</brief_summary>
	<brief_title>Eluna Family / Sentus BP Master Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>Patient willing participate study provide write informed consent Patient meet standard indication pacemaker CRTP CRTD therapy Patient accept Home MonitoringÂ® concept Patient legal capacity ability consent Patient contraindication pacemaker CRTP CRTD therapy Patient age 18 Pregnant breastfeed woman Cardiac surgery plan within next 6 month Life expectancy le 12 month Participation another cardiac clinical investigation active treatment arm Group B : Currently implant endocardial epicardial LV lead prior attempt place LV lead ( CRT implant )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Eluna pacemaker family</keyword>
	<keyword>Sentus OTW BP L leave ventricular lead</keyword>
	<keyword>Bradycardia</keyword>
	<keyword>SADE-free rate</keyword>
</DOC>